Epitomee Medical Ltd.
Develops ingestible therapeutic devices for weight management and targeted drug delivery.
EPIT | TA
Overview
Corporate Details
- ISIN(s):
- IL0011825911
- LEI:
- Country:
- Israel
- Address:
- 17 Hatochen, 3079892 Caesarea
- Website:
- https://epitomeemedical.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Epitomee Medical Ltd. is a medical technology company that develops and commercializes ingestible therapeutic devices to treat chronic diseases. Its core platform technology centers on a self-ingested, swallowable capsule designed to deploy targeted therapies at specific locations within the gastrointestinal (GI) tract. The devices function for a predetermined duration before dissolving and being naturally expelled. This adaptable platform enables mechano-sensory stimulation, targeted drug delivery, and absorption management. The company's primary focus areas are weight management and the delivery of biologic drugs. Epitomee has received FDA clearance for its drug-free weight management capsule. The company collaborates with industry leaders to bring its innovative therapies to market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-11-30 10:58 |
Investor Presentation
Investor Presentation
|
Hebrew (modern) | 1.1 MB | ||
| 2023-11-30 10:58 |
Share Issue/Capital Change
Investor Presentation
|
Russian | 42.4 KB | ||
| 2023-09-12 10:37 |
Investor Presentation
Presentation- September 2023
|
English | 2.4 MB | ||
| 2023-09-12 10:37 |
Registration Form
Presentation- September 2023
|
Russian | 42.1 KB | ||
| 2022-03-29 13:15 |
Regulatory News Service
TASE Indices – Epitomee Med Factor Correction
|
Hebrew (modern) | 158.0 KB | ||
| 2022-02-17 19:30 |
Regulatory News Service
Will be added to the respective indices thru the fast track on March 3rd , 2022…
|
Hebrew (modern) | 327.0 KB | ||
| 2021-12-21 18:44 |
Regulatory News Service
Will be add to the TA-Tech Elite Index On March 3rd, 2021 thru the Fast Track
|
Hebrew (modern) | 161.3 KB | ||
| 2021-12-14 16:03 |
Regulatory News Service
Opening of Trading On December 15 2021-EPITOMEE MED
|
Hebrew (modern) | 175.6 KB | ||
| 2021-12-14 15:03 |
Regulatory News Service
Opening of Trading On December 15 2021-EPITOMEE MED
|
Hebrew (modern) | 175.6 KB | ||
| 2021-12-13 12:45 |
Regulatory News Service
Identifying Details of New Security- EPITOMEE MED
|
Hebrew (modern) | 174.7 KB | ||
| 2021-11-29 18:33 |
Investor Presentation
Investor Presentation-November 2021
|
English | 2.8 MB | ||
| 2021-11-29 18:33 |
Pre-Annual General Meeting Information
Investor Presentation-November 2021
|
Russian | 41.6 KB |
Automate Your Workflow. Get a real-time feed of all Epitomee Medical Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Epitomee Medical Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Epitomee Medical Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
